GlassScriptPhysician profile
Peter O Carey
NPI 1316994742
$2,878.88
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,184 · 2020: $603 · 2021: $929 · 2022: $164.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $589.59 | 2019-2022 | |
| Astellas Pharma US INC | $464.00 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $355.47 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $213.77 | 2019-2021 | |
| Pfizer INC. | $198.50 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $79.07 | 2021-2022 | |
| Urogen Pharma, INC. | $76.89 | 2020-2021 | |
| Myovant Sciences INC. | $69.46 | 2021 | |
| Blue Earth Diagnostics | $67.32 | 2019-2021 | |
| Boston Scientific Corporation | $65.18 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.07 | 2019-2021 | |
| Amgen INC. | $62.00 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $50.72 | 2021 | |
| Abbvie INC. | $48.87 | 2019 | |
| Allergan, INC. | $47.02 | 2019-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $39.50 | 2020-2021 | |
| Dentsply Ih INC. | $37.85 | 2021 | |
| Olympus America INC. | $34.74 | 2021-2022 | |
| Clarus Therapeutics INC. | $34.35 | 2021 | |
| Coloplast Corp | $30.41 | 2019-2020 | |
| Antares Pharma, INC. | $28.17 | 2019-2020 | |
| Teleflex LLC | $27.54 | 2021-2022 | |
| Rochester Medical Corporation | $25.64 | 2019-2020 | |
| Ibsa Pharma INC. | $24.62 | 2022 | |
| Neotract INC. | $23.67 | 2019 | |
| Ambu INC. | $23.22 | 2021 | |
| Therapeuticsmd, INC. | $20.51 | 2019 | |
| Travere Therapeutics, INC. | $17.45 | 2019 | |
| Photocure INC | $17.27 | 2021 | |
| Acerus Pharmaceuticals Corporation | $16.76 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $14.65 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Carey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.